TNF is involved in the pathogenesis of autoimmune and inflammatory diseases such as rheumatoid arthritis, irritable bowel syndrome, psoriasis, psoriatic arthritis, and ankylosing spondylitis (7), which has led to the development of Food and Drug Administration–approved TNF inhibitors to treat these disorders (12). The gene discussed is TNF; the disease is irritable bowel syndrome.